Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data and Double …
US Health care reform had a 1.5% negative effect on net sales in the second quarter. — US net sales increased 4% to $3.1 billion in the second quarter of …
See all stories on this topic »